InsiderChief Executive Officer

Emily M. Leproust Insider Trading Activity

Every SEC Form 4 transaction reported by Emily M. Leproust, sourced directly from SEC EDGAR and updated as new filings are accepted.

Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Is Emily M. Leproust buying or selling?

Emily M. Leproust reported 0 open-market buys ($0) and 96 sells ($175.0M) across 96 Form 4 filings at 1 company — a net selling position of $175.0M.

Source: SEC EDGAR Form 4

What stands out

  • All 96 of Emily M. Leproust's Form 4 filings are for one company, Twist Bioscience Corp (TWST).
  • The most recent Form 4 was accepted on Oct 7, 2026 (11 days ago).
  • In the last 12 months: no open-market purchases and 28 sales ($101.7M).
  • The largest open-market sale in the last 12 months was $56.3M of Twist Bioscience Corp (TWST) on Sep 21, 2026. SEC ↗

Key Statistics (as of Oct 7, 2026)

Total Form 4 filings
96
SEC EDGAR
Companies
1
Buys (0)
$0
Sells (96)
$175.0M

Insider sentiment

Net selling

Net insider flow of $175.0M in net selling, filed between May 23, 2020 – Oct 7, 2026.

Companies Emily M. Leproust files for

#CompanyForm 4 filings
1TWSTTwist Bioscience Corp96

Recent Emily M. Leproust transactions

DateTickerRoleTypeSharesValueFiling
Oct 7, 2026TWSTChief Executive OfficerSale4.5K$919.4KSEC ↗
Oct 5, 2026TWSTChief Executive OfficerSale46.4K$8.8MSEC ↗
Sep 25, 2026TWSTChief Executive OfficerSale5.2K$922.9KSEC ↗
Sep 23, 2026TWSTChief Executive OfficerSale1.7K$279.2KSEC ↗
Sep 21, 2026TWSTChief Executive OfficerSale356.5K$56.3MSEC ↗
Sep 10, 2026TWSTChief Executive OfficerSale2.3K$282.3KSEC ↗
Aug 27, 2026TWSTChief Executive OfficerSale41.6K$6.3MSEC ↗
Aug 25, 2026TWSTChief Executive OfficerSale6.6K$923.3KSEC ↗
Aug 14, 2026TWSTChief Executive OfficerSale20.0K$2.5MSEC ↗
Aug 12, 2026TWSTChief Executive OfficerSale113.3K$14.2MSEC ↗
Aug 5, 2026TWSTChief Executive OfficerSale5.1K$435.2KSEC ↗
Jun 26, 2026TWSTChief Executive OfficerSale18.9K$1.8MSEC ↗
Jun 24, 2026TWSTChief Executive OfficerSale1.7K$147.4KSEC ↗
Jun 10, 2026TWSTChief Executive OfficerSale2.3K$158.2KSEC ↗
Jun 1, 2026TWSTChief Executive OfficerSale16.5K$1.1MSEC ↗
May 28, 2026TWSTChief Executive OfficerSale49.3K$3.2MSEC ↗
May 26, 2026TWSTChief Executive OfficerSale6.9K$366.8KSEC ↗
May 6, 2026TWSTChief Executive OfficerSale5.1K$293.0KSEC ↗
Apr 23, 2026TWSTChief Executive OfficerSale9.7K$631.0KSEC ↗
Mar 24, 2026TWSTChief Executive OfficerSale1.7K$76.3KSEC ↗
Mar 10, 2026TWSTChief Executive OfficerSale2.4K$112.5KSEC ↗
Feb 25, 2026TWSTChief Executive OfficerSale7.2K$336.5KSEC ↗
Feb 5, 2026TWSTChief Executive OfficerSale5.0K$232.9KSEC ↗
Dec 23, 2025TWSTChief Executive OfficerSale1.6K$55.5KSEC ↗
Dec 10, 2025TWSTChief Executive OfficerSale2.3K$74.1KSEC ↗

Showing the 25 most recent filings of 96. Screen every filing.

Emily M. Leproust insider trading FAQ

Is Emily M. Leproust buying or selling?

Across 96 SEC Form 4 filings, Emily M. Leproust reported 0 open-market purchases totaling $0 and 96 sales totaling $175.0M — a net selling position of $175.0M.

Which companies does Emily M. Leproust file Form 4s for?

Emily M. Leproust has reported insider transactions at 1 company, most often Twist Bioscience Corp (TWST).

How far back does Emily M. Leproust's filing history go?

Trabud holds Emily M. Leproust's SEC Form 4 filings from May 23, 2020 – Oct 7, 2026, sourced directly from SEC EDGAR.

Where does Trabud get Emily M. Leproust's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Track Emily M. Leproust and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener